Author

Yuta Mishima

Harvard UniversityORCID 0000-0003-4945-7346Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Assay:imaging· 1 Research Focus:metabolism & bioenergetics· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

Biljana ČuljkovićiD· 1 shared Christian BachiD· 1 shared Daniel Geoffrey TeneniD· 1 shared Fang ZhouiD· 1 shared Feng LiiD· 1 shared Hiroshi OhnoiD· 1 shared Hitoshi ShimanoiD· 1 shared Katherine L. B. BordeniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Biljana ČuljkovićORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyFEBS JournalPeer-reviewedOct 17, 2025

Label-free imaging of intracellular structures in living mammalian cells via external apodization phase-contrast microscopy

Hiroshi Ohno, Takenori Nishimura, Kenta Kainoh…·Hitoshi Shimano

This study introduces ExAPC microscopy for label-free visualization of intracellular structures, showing its ability to resolve biomolecular condensates, lipid droplets, and mitochondria with high spatiotemporal resolution.

2 citations

mouseimaging

𝕏 PostBluesky

Molecular BiologybioRxivPreprintFeb 10, 2025

Posttranscriptional activity of the eukaryotic translation initiation factoreIF4E contributes to HoxA9-driven leukemogenesis

Fang Zhou, Biljana Čuljković, Christian Bach…·Daniel Geoffrey Tenen

This study shows that disrupting the interaction between HoxA9 and eIF4E delays AML onset and reduces disease penetrance, suggesting eIF4E as a therapeutic target in HoxA9-driven leukemia.

DOI 10.1101/2025.02.10.637540

mouseexperimental assay

𝕏 PostBluesky